Impact of CDK12 loss on immune response in TCGA prostate tumors (2021)
- Authors:
- USP affiliated authors: SQUIRE, JEREMY ANDREW - FMRP ; DUTRA, WILLIAM LAUTERT - FMRP
- Unidade: FMRP
- Subjects: GENES SUPRESSORES; NEOPLASIAS PROSTÁTICAS; IMUNOTERAPIA; EXPRESSÃO GÊNICA
- Keywords: Tumor suppressor gene; Transcriptomics; Innate and adaptive immune system
- Language: Inglês
- Imprenta:
- Publisher: Sociedade Brasileira de Genética - SBG
- Publisher place: [Ribeirão Preto]
- Date published: 2021
- Source:
- Título do periódico: Resumos
- Conference titles: Congresso Brasileiro de Genética = Brazilian Congress of Genetics
-
ABNT
DUTRA, William Lautert et al. Impact of CDK12 loss on immune response in TCGA prostate tumors. 2021, Anais.. [Ribeirão Preto]: Sociedade Brasileira de Genética - SBG, 2021. Disponível em: https://www.sbg.org.br/anais. Acesso em: 24 abr. 2024. -
APA
Dutra, W. L., Vidotto, T., Melo, C. M., & Squire, J. A. (2021). Impact of CDK12 loss on immune response in TCGA prostate tumors. In Resumos. [Ribeirão Preto]: Sociedade Brasileira de Genética - SBG. Recuperado de https://www.sbg.org.br/anais -
NLM
Dutra WL, Vidotto T, Melo CM, Squire JA. Impact of CDK12 loss on immune response in TCGA prostate tumors [Internet]. Resumos. 2021 ;[citado 2024 abr. 24 ] Available from: https://www.sbg.org.br/anais -
Vancouver
Dutra WL, Vidotto T, Melo CM, Squire JA. Impact of CDK12 loss on immune response in TCGA prostate tumors [Internet]. Resumos. 2021 ;[citado 2024 abr. 24 ] Available from: https://www.sbg.org.br/anais - Trannscriptomics and immune response in human cancer
- Differential gene expression related to TMPRSS2-ERG fusion, CDK12, RB1, TP53, AR and ZEB1 based on transcriptomic analysis of the TCGA PRAD cohort
- Impact of CDK12 mutation on immune response in prostate cancer
- Analysis of the impact of ZEB1 expression on pathway enrichment and immune cell abundance in prostate cancer
- TCGA analysis identifies distinct genomic features of oncogenic progression and outcome associated with hemizygous PTEN loss tumors
- Recurrent copy number alterations in prostate cancer: an in silico meta-analysis of publicly available genomic data
- Application of fluorescence in situ hybridization (FISH) and immunohistochemistry (IHC) for detecting PTEN loss in diagnostic prostate cancer needle biopsies
- In prostate cancer needle biopsies, detections of PTEN loss by fluorescence in sity hybridization (FISH) and by immunohistochemistry (IHC) are concordant and show consistent association with upgrading
- Quantitative assessment of PTEN loss (qPTEN) is strongly associated with biochemical recurrence and may improve treatment decisions after surgery
- Tumour genomic and microenvironmental heterogeneity for integrated prediction of 5-year biochemical recurrence of prostate cancer: a retrospective cohort study
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
